Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05236062 · ClinicalTrials.gov registry record · NA
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
A NA study of Graft Vs Host Disease and Chronic Graft Versus Host Disease, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 2
- Study locations
NCT05236062 is a NA study of Graft Vs Host Disease and Chronic Graft Versus Host Disease that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 36 participants, below the 137-participant average among 36 other Graft Vs Host Disease trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05236062, a NA study of Graft Vs Host Disease and Chronic Graft Versus Host Disease, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is about determining if an aerobic and resistance exercise intervention is feasible in patients diagnosed with acute or chronic GVHD (Graft-Versus-Host Disease) after having an allogeneic stem cell transplant. The names of the study interventions involved in this study are: * Aerobic and resistance exercise (A+R) - Home-based aerobic and resistance exercise program * Attention control (AC) - Home-based stretching program
Conditions Studied
Interventions
- BEHAVIORAL Exercise
- BEHAVIORAL Attention control
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-04-14 |
| Est. Completion | 2027-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05236062
The ClinicalTrials.gov registry entry for NCT05236062 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 137-participant average among 36 other Graft Vs Host Disease trials with a reported enrollment target (74% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Graft Vs Host Disease appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.
NCT05236062 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05236062 about?
NCT05236062 is a clinical study titled "Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial". This study is about determining if an aerobic and resistance exercise intervention is feasible in patients diagnosed with acute or chronic GVHD (Graft-Versus-Host Disease) after having an allogeneic stem cell transplant. The names of the study interventions involved in this study are: * Aerobic an...
What is the current status of trial NCT05236062?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2022-04-14. Estimated completion is 2027-09-09.
What conditions does trial NCT05236062 study?
This clinical trial studies the following conditions: Graft Vs Host Disease, Chronic Graft Versus Host Disease, Acute-graft-versus-host Disease.
What interventions are being tested in trial NCT05236062?
The interventions under investigation include: Exercise (BEHAVIORAL), Attention control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05236062?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05236062 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Graft Vs Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
RECRUITING · NA
-
Horizons Chronic Graft-Versus-Host-Disease Study
ACTIVE NOT RECRUITING · NA
-
Multidisciplinary Intervention In Chronic GVHD
ACTIVE NOT RECRUITING · NA
-
Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
ACTIVE NOT RECRUITING · NA
-
Topical Vitamin D in Acute Graft Versus Host Disease of the Skin
COMPLETED · NA
-
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
RECRUITING
Explore more on PlainTrial
Graft Vs Host Disease
All registered trials for this condition
Chronic Graft Versus Host Disease
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.